2022 年临床疫苗学更新 (CVU) 现已开放注册！
Registrations are now open for the annual Clinical Vaccinology Update (CVU), taking place in person on Friday 28th October.
我们的面对面活动将通过主题演讲和互动分组会议提供专业发展，以及与同行交流和交流的机会。
立即注册，不要错过这个机会，聆听顶尖专家介绍免疫领域的最新发展和趋势。
To find out more about the program and to register, please click on the link below to our Events page.
MVEC：临床疫苗学更新 (CVU) 2022
MVEC 免疫技能研讨会现已开放报名 – 2022 年 11 月 25 日星期五
MVEC are pleased to announce that registrations for our 免疫技能研讨会 taking place on Friday 25日 November are now open.
The full day interactive, face to face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing:
- 有效的疫苗沟通
- 错误预防和管理
- 过敏反应和急性应激反应。
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time).
地点： The HELP Precinct, The HELP Precinct, 皇家儿童医院, 50 Flemington Road, Parkville
时间： 上午 8:30 至下午 4:30
成本： $290.00（含餐饮）
Register for the Immunisation Skills Workshop now via the link below!
MVEC Immunisation Skills Workshop
新的免疫参考页面 – 猴痘
猴痘是一种病毒性人畜共患病（一种从动物传播给人类的感染）。它是由属于 正痘病毒 genus (which also causes the variola virus responsible for smallpox disease and the vaccinia virus, which is used in smallpox vaccines). Since the eradication of smallpox in 1980, monkeypox has become the most important orthopoxvirus affecting humans, however, causes less severe disease than smallpox.
The incubation period of monkeypox is usually 7-14 days, with initial symptoms of monkeypox including fever, headache, backache and muscle aches, fatigue and lymphadenopathy. Historically, smallpox vaccines have been used in the prevention of smallpox infection, however, they are also likely to be effective against monkeypox.
There are two types of smallpox vaccines registered for use in Australia for the prevention of monkeypox, ACAM2000™ and JYNNEOS®.
Our new reference page outlines symptoms, transmission routes, epidemiology, current vaccine recommendations and links to the latest resources.
For further information, click on the link below:
MVEC：猴痘
MVEC 的免疫技能研讨会 - 宣布新日期
由于维多利亚州 COVID-19 病例数增加以及皇家儿童医院 (RCH) 实施访客限制，我们原定于 9 月 2 日在 RCH 举行的免疫技能研讨会已改期为 25 日星期五日 十一月。我们期待在接下来的几周内公布计划详情并开放此活动的注册。
Save the date for MVEC’s Immunisation Skills Workshop – Friday 2 September 2022
MVEC are pleased to invite you to save the date for our 免疫技能研讨会 taking place on Friday 2nd September.
The full day interactive, face-to-face workshop is MVEC’s newest learning opportunity designed to provide education and upskilling in the principles and processes of managing:
- 有效的疫苗沟通
- 错误预防和管理
- anaphylaxis and acute stress responses
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time).
Further program details and a link to register will be available via our 活动页面 soon.
A recording of the 28th April CVU mini is now available
Thank you to all who attended our recent CVU miniseries event 冬季准备：COVID-19 和流感 on Thursday 28th April 2022.
This interactive webinar covered the following updates:
- COVID-19 疫苗：保持最新状态
- 老年人冬季 COVID-19 加强剂量和流感给药
- 流感：COVID-19 后的情况
A recording of this event is now available via our education portal.
To access this recording please follow the link below:
Science: Pandemic propels global effort to study rare vaccine side effects
The Global Vaccine Data Network (GVDN) is the largest ever vaccine safety project involving more than 20 countries and data from more than 250 million people vaccinated against COVID-19.
It aims to investigate and understand rare vaccine side effects such as myocarditis, 血栓形成伴血小板减少综合征 和 吉兰-巴利综合征 following COVID-19 vaccination which may lead to the prediction, treatment and prevention of side effects.
The following article discusses the importance of globalising vaccine safety research through international collaboration to improve vaccine safety.
To read more, please click on the link below.
Science: Pandemic propels global effort to study rare vaccine side effects
Registrations now open for the April CVU mini event
MVEC's first Clinical Vaccinology Update (CVU) miniseries event of the year on 冬季准备：COVID-19 和流感 will be held virtually on Thursday 28th April 2022. This CVU mini will provide an update on:
- COVID-19 疫苗：保持最新状态
- 老年人冬季 COVID-19 加强剂量和流感给药
- 流感：COVID-19 后的情况
Further details can be found via our Events page and the link below:
Save the date for our first CVU mini event for 2022: Thursday 28 April 2022
MVEC invites you to Save the Date for first CVU mini for 2022!
Date: Thursday 28 April, 2022
Time: 7:00pm – 8:30pm AEST
Further details and registration information will be available soon on our Events page 和 教育门户.
To keep up to date with our latest news, including upcoming events, you can subscribe to our weekly newsletter.
New reference page: Japanese encephalitis
An outbreak of Japanese encephalitis virus (JEV), a rare but potentially lethal mosquito-transmitted disease that can cause inflammation of the brain has been detected in Queensland, New South Wales, Victoria and South Australia. While most infections are asymptomatic, it is currently the leading cause of vaccine-preventable encephalitis in Asia.
Our new reference page: Japanese encephalitis addresses key factors including:
- What is JEV?
- What to look for?
- How it is transmitted?
- Epidemiological information
- Prevention
- Vaccine information
Follow the link to view the full reference page:
日本脑炎